uniQure N.V. will release its third quarter 2025 financial results on November 10, 2025, followed by a conference call at 8:30 a.m. ET. The event will be webcast on the company’s website, with a replay available for 90 days. Analysts can participate in the Q&A session by dialing (646) 307-1963. uniQure is a gene therapy company focused on delivering potentially curative treatments, with recent approvals for hemophilia B. The company is also developing gene therapies for Huntington’s disease, ALS, and other severe conditions. Learn more at www.uniQure.com.

Read more at GlobeNewswire: uniQure to Announce Third Quarter 2025 Financial Results